What happened: A new triple-action cancer jab has shown the ability to completely eliminate tumours in patients whose cancers were resistant to chemotherapy and immunotherapy, according to an international trial across 11 countries.
Why it matters:
- Offers a potential new treatment for patients with advanced, treatment-resistant cancers.
- Could change cancer care by providing an option when other therapies fail.
MNN Take: The trial demonstrates promising results for a novel cancer vaccine approach, highlighting progress in tackling difficult-to-treat tumours. Further studies will be needed to confirm long-term effectiveness and safety.
Sources: Guardian UK